Publications by authors named "Manuel Botana"

Claim this Profile
L
Lipid-lowering drug therapy for reducing cardiovascular risk in diabetes. A clinical view of the Cardiovascular Disease Working Group of the Spanish Diabetes Society.
Juan Pedro-Botet, Francisco Arrieta, Manuel Botana, José A Gimeno-Orna, José I Martínez-Montoro

Endocrinol Diabetes Nutr (Engl Ed)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Montse Guardiola, Pere Rehues, Núria Amigó, Francisco Arrieta, Manuel Botana

Eur J Clin Invest· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Manuel Botana

Nefrologia (Engl Ed)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophilin B serum levels present variations across the menstrual cycle.
Rebeca Alvariño, Cristina Gil-Mouce, Manuel A Botana, Sandra Gegunde, Jesús González-Jartín, Luis M Botana

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
Anna Norhammar, Johan Bodegard, Marc Vanderheyden, Navdeep Tangri, Avraham Karasik, Manuel Botana

Heart· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study.
Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Manuel Botana

Lancet Reg Health Eur· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Manuel Botana

Nefrologia (Engl Ed)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
Anna Norhammar, Johan Bodegard, Jan W Eriksson, Hermann Haller, Gerard C M Linssen, Manuel Botana

Diabetes Obes Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Cardiorenal Complications with Sodium-Glucose Cotransporter Type 2 Inhibitors: A Narrative Review.
Manuel Botana, Javier Escalada, Ángel Merchante, Rebeca Reyes, Pedro Rozas

Diabetes Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of outcomes in a Spanish population with chronic kidney disease.
Roberto Alcázar, Carlos Escobar, Beatriz Palacios, Unai Aranda, Luis Varela, Manuel Botana

Clin Kidney J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease.
Ana Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Manuel Botana

Clin Kidney J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study.
Cristóbal Morales, Juan Francisco Merino-Torres, Paloma Moreno-Moreno, María Lainez, Iñigo Tejado, Manuel A Botana

Drugs Context· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DAPA-RWE: a retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain.
Cristobal Morales, Virginia Bellido, Cristina Tejera, Fernando Goñi, Rafael Palomares, Manuel A Botana

J Comp Eff Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and healthcare utilisation of patients with chronic kidney disease in Spain.
Carlos Escobar, Beatriz Palacios, Unai Aranda, Margarita Capel, Antoni Sicras, Manuel Botana

BMC Health Serv Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain.
Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Manuel Botana

Nefrologia (Engl Ed)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and healthcare utilisation of patients with heart failure in Spain.
Carlos Escobar, Luis Varela, Beatriz Palacios, Margarita Capel, Antoni Sicras, Manuel Botana

BMC Health Serv Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range".
Ana de Hollanda, Albert Lecube, Miguel Angel Rubio, Enric Sánchez, Núria Vilarrasa, Manuel Antonio Botana

J Clin Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from northwest Spain.
Miguel A Gonzalez-Gay, Ali H Hajeer, Carlos Garcia-Porrua, Adele Dababneh, Mahsa M Amoli, Manuel A Botana

J Rheumatol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis